🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II study augmenting TAK-659 action in relapsed/refractory...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2019-09-20
Trial ID
NCT04079738
The main aim of this study is to check side effects and results in adults w...
Status
Active Not Recruiting
Location
Anhui Cancer Hospital
Start Date
2021-10-29
Trial ID
NCT05013190
Treatments Being Tested
This phase 2 trial studies how well ixazomib(MLN9708) works in treating stu...
Status
Terminated
Location
Stanford University Cancer Institute
Start Date
2014-03
Trial ID
NCT02030405
Treatments Being Tested
This is a randomized, Phase 2 study involving two arms evaluating the effic...
Status
Terminated
Location
James R Berenson, MD, Inc.
Start Date
2019-03-01
Trial ID
NCT03733691
Treatments Being Tested
The purpose of this pilot study is to examine changes in patient-reported o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-05
Trial ID
NCT03903406
Treatments Being Tested
Adult patients with a confirmed diagnosis of symptomatic and relapsed and/o...
Status
Active Not Recruiting
Location
Emek Medical Center
Start Date
2021-03-25
Trial ID
NCT04790474
Treatments Being Tested
ONC201 is a novel dopamine receptor D2 antagonist that is able to activate ...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2018-03-26
Trial ID
NCT03492138
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ixazomib an...
Status
Completed
Location
Mayo Clinic
Start Date
2014-06-30
Trial ID
NCT02119468
Treatments Being Tested
This study will assess the efficacy of daratumumab in combination with ixaz...
Status
Unknown
Location
General Hospital of Athens "Alexandra"
Start Date
2018-12
Trial ID
NCT03746652
Treatments Being Tested
The purpose of this study is to determine the effect of ixazomib maintenanc...
Status
Completed
Location
Robert A Moss MD FACP Inc
Start Date
2015-04-09
Trial ID
NCT02312258